Our work in drug-resistant TB
The Union advocates for increased research and development, and conducts clinical trials to reduce treatment time and improve outcomes for patients in countries with the highest burdens of disease.
The Union also provides practical and experience-based support to countries implementing care for people with DR-TB. Our expertise is based on our extensive research with partners supporting the nine-month regimen, including partnering on the first randomised control trial into a new regimen for multidrug-resistant TB (TREAT TB).
With the new World Health Organization guidelines focusing on shorter, all oral, regimens for MDR-TB, The Union continues to support countries to implement the latest evidence-based treatments.
TREAT TB
Read more about TREAT TB (Technology, Research, Education and Technical Assistance for Tuberculosis), an ambitious initiative that was launched by The Union, seeking to contribute new knowledge regarding shorter, more tolerable treatment regimens for MDR-TB.
OTHER AREAS OF OUR WORK IN TUBERCULOSIS
You might also be interested in our work on child and adolescent TB and TB-HIV, TB-diabetes and co-morbidities.
The Union used an operational research approach to test a shortened treatment regimen for multidrug-resistant TB. The study first demonstrated a greater than 80% success rate in Bangladesh, Cameroon and Niger and The Union continued to work to develop and implement shorter more effective regimens for the treatment of MDR-TB.
Learn more
Understand the issues with our fact sheets
DR-TB Union news
Accelerating an end to TB in urban India
In close collaboration with national and local partners, The Union is leading two initiatives designed to accelerate the elimination of…
Accelerating TB elimination through innovation in India
Last week, the ‘India Innovation Summit – Pioneering solutions to End TB’ was held at Bharat Mandapam, New Delhi.
The Summit,…
Enhancing TB prevention across South-East Asia
A multi-country study aiming to improve the retention of people in different phases of care for TB prevention across South-East Asia is…
New Union India Office Director appointed
The Union is delighted to announce the appointment of Nidhi Bansal as the Country Director for The Union India Office.
…
Innovative model for ending TB in urban settings launches in India
A new project to end TB in urban settings has been launched in the Medchal Malkajgiri District of Hyderabad. The ‘Swasthya Nagarm’…
The Union extends vital health programmes in Myanmar through new Global Fund grant
Among ongoing efforts to combat tuberculosis (TB), drug-resistant tuberculosis (DR-TB), and HIV/AIDS, The Union Office in Myanmar, in…